THE RELATIONSHIP BETWEEN C-ERBB-2 EXPRESSION, S-PHASE FRACTION AND PROGNOSIS IN BREAST-CANCER

被引:142
作者
OREILLY, SM
BARNES, DM
CAMPLEJOHN, RS
BARTKOVA, J
GREGORY, WM
RICHARDS, MA
机构
[1] GUYS & ST THOMAS HOSP, IMPERIAL CANC RES FUND, CLIN ONCOL UNIT, LONDON SE1 9RT, ENGLAND
[2] UNITED MED & DENT SCH GUYS & ST THOMAS HOSP, ST THOMAS HOSP, RICHARD DIMBLEBY DEPT CANC RES, LONDON SE1 7EH, ENGLAND
[3] RES INST CLIN & EXPTL PATHOL, BRNO, CZECHOSLOVAKIA
关键词
D O I
10.1038/bjc.1991.102
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The relationship between c-erbB-2 gene expression (assessed immunohistochemically), S-phase fraction (SPF) and prognosis has been analysed in 172 women with primary breast cancer, c-erbB-2 staining was independent of age, tumour size, number of nodes involved, tumour grade and DNA ploidy, but was more common in oestrogen receptor (ER) negative tumours (P = 0.02) and progesterone receptor (PgR) negative tumours (P = 0.03). A weak correlation between c-erbB-2 staining and SPF was observed (r = 0.18). Amongst women with node negative disease, SPF was significantly related to relapse free survival (RFS, P = 0.04) while c-erbB-2 staining was not (P = 0.2). In contrast, both SPF (P = 0.002) and c-erbB-2 staining (P = 0.016) provided significant prognostic information on RFS for women with node positive disease. Multivariate analysis showed that c-erbB-2 staining and SPF gave independent information on RFS for women with node positive disease.
引用
收藏
页码:444 / 446
页数:3
相关论文
共 25 条
  • [1] THE PRODUCT OF THE HUMAN C-ERBB-2 GENE - A 185-KILODALTON GLYCOPROTEIN WITH TYROSINE KINASE-ACTIVITY
    AKIYAMA, T
    SUDO, C
    OGAWARA, H
    TOYOSHIMA, K
    YAMAMOTO, T
    [J]. SCIENCE, 1986, 232 (4758) : 1644 - 1646
  • [2] AMPLIFICATION OF C-ERBB-2 AND AGGRESSIVE HUMAN-BREAST TUMORS
    ALI, IU
    CAMPBELL, G
    LIDEREAU, R
    CALLAHAN, R
    [J]. SCIENCE, 1988, 240 (4860) : 1795 - 1796
  • [3] ANALYSIS OF PCP-DATA TO DETERMINE FRACTION OF CELLS IN VARIOUS PHASES OF CELL-CYCLE
    BAISCH, H
    GOHDE, W
    LINDEN, WA
    [J]. RADIATION AND ENVIRONMENTAL BIOPHYSICS, 1975, 12 (01) : 31 - 39
  • [4] AN IMMUNOHISTOCHEMICAL EVALUATION OF C-ERB-2 EXPRESSION IN HUMAN-BREAST CARCINOMA
    BARNES, DM
    LAMMIE, GA
    MILLIS, RR
    GULLICK, WL
    ALLEN, DS
    ALTMAN, DG
    [J]. BRITISH JOURNAL OF CANCER, 1988, 58 (04) : 448 - 452
  • [5] BLOOM HJG, 1957, BRIT J CANCER, V5, P173
  • [6] BORG A, 1989, NORDIC CANCER UNION
  • [7] MEASUREMENT OF S-PHASE FRACTIONS IN LYMPHOID-TISSUE COMPARING FRESH VERSUS PARAFFIN-EMBEDDED TISSUE AND 4',6'-DIAMIDINO-2 PHENYLINDOLE DIHYDROCHLORIDE VERSUS PROPIDIUM IODIDE STAINING
    CAMPLEJOHN, RS
    MACARTNEY, JC
    MORRIS, RW
    [J]. CYTOMETRY, 1989, 10 (04): : 410 - 416
  • [8] DOLAN J, 1989, J PATHOL, V158, pA345
  • [9] EXPRESSION OF THE C-ERBB-2 PROTEIN IN NORMAL AND TRANSFORMED-CELLS
    GULLICK, WJ
    BERGER, MS
    BENNETT, PLP
    ROTHBARD, JB
    WATERFIELD, MD
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1987, 40 (02) : 246 - 254
  • [10] C-ERBB-2 EXPRESSION IN BENIGN AND MALIGNANT BREAST DISEASE
    GUSTERSON, BA
    MACHIN, LG
    GULLICK, WJ
    GIBBS, NM
    POWLES, TJ
    ELLIOTT, C
    ASHLEY, S
    MONAGHAN, P
    HARRISON, S
    [J]. BRITISH JOURNAL OF CANCER, 1988, 58 (04) : 453 - 457